SS 31 Peptide: A Breakthrough in Mitochondrial Therapy
SS 31 peptide, known as Bendavia or MTP-131, is a breakthrough in mitochondrial-targeted therapeutics, designed to mitigate oxidative stress and maintain mitochondrial function. By binding to cardiolipin in the inner mitochondrial membrane, it stabilizes mitochondria, reducing reactive oxygen species and preventing dysfunction. This offers potential treatments for neurodegenerative diseases, heart conditions, and muscle disorders. Ongoing research highlights its promise in addressing various conditions linked to mitochondrial health, positioning SS 31 as a significant therapeutic advancement.

